Thermo Fisher Scientific's Q3 2026 Earnings: What to Expect Thermo Fisher Scientific is poised to release its third-quarter results later this month, and analysts project a double-digit earnings rise. Barchart · Oct 9
Is Thermo Fisher Scientific Stock Outperforming the Nasdaq? Thermo Fisher Scientific has outperformed the Nasdaq over the past year, yet Wall Street analysts remain bullish on the stock, reflecting confidence that its strong growth trajectory has further room to run. Barchart · Aug 31
Thermo Fisher Scientific Stock: Analyst Estimates & Ratings Thermo Fisher Scientific has underperformed the broader market over the past year, yet analysts remain highly bullish about the stock’s prospects. Barchart · Aug 17
Billionaire Investor Dumps Thermo Fisher, Cuts Danaher As He Pares Life Sciences Tools Bets Hedge fund billionaire Daniel Loeb reduced its exposure to life Sciences Tools & Services sector by cutting stake in Danaher Corporation (NYSE:DHR) and fully exiting position in Thermo Fisher Scientific Inc (NYSE:TMO) in the first quarter of 2026. Benzinga · Jul 24
Thermo Fisher Scientific Earnings Preview: What to Expect Thermo Fisher Scientific will release its second-quarter earnings soon, and analysts anticipate a single-digit bottom-line growth. Barchart · Jun 30
Is Quest Diagnostics Stock Underperforming the S&P 500? While Quest Diagnostics has lagged behind the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s prospects. Barchart · Jun 19
Is Mettler-Toledo Stock Underperforming the S&P 500? Although Mettler-Toledo has lagged behind the S&P 500 Index over the past year, analysts are moderately optimistic about the stock’s prospects. Barchart · Jun 11
Is Thermo Fisher Scientific Stock Underperforming the S&P 500? Despite Thermo Fisher Scientific's underperformance relative to the SPX over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects. Barchart · May 29
Do Wall Street Analysts Like Thermo Fisher Scientific Stock? While Thermo Fisher Scientific has considerably underperformed the broader market over the past 52 weeks, Wall Street analysts maintain a highly optimistic outlook about the stock’s prospects. Barchart · May 18
Champions Cup final will have independent TV director in charge An independent director will be in charge of the Champions Cup final TV coverage after Bath were left unhappy some camera angles were unavailable to the TMO in their semi-final loss The Guardian - UK · May 4
The Often-Missed Corner of Healthcare That Wall Street Is Loving Makers of crucial lab equipment and materials for the healthcare industry play a vital, though often overlooked, role for some higher-risk companies. MarketBeat · Mar 29
What You Need to Know Ahead of Thermo Fisher Scientific's Earnings Release Thermo Fisher Scientific will release its first-quarter earnings soon, and analysts anticipate a single-digit bottom-line growth. Barchart · Mar 27
Waratahs blow it to suffer Super Rugby Pacific Blues The NSW Waratahs have been left to lament squandering half a dozen try-scoring chances in a 35-20 Super Rugby Pacific loss to the Blues in Sydney. AAP · Mar 21
Steve Borthwick admits England are ‘hurting’ after worst ever Six Nations England produced their best performance of the competition as they fell to a late 48-46 loss to France, which saw them finish in fifth with one win. The Independent UK · Mar 15
The Independent UK · Mar 9 France flanker Oscar Jegou cited over alleged gouging incident in Scotland defeat Jegou appeared to make contact with the eye of Scotland’s Ewan Ashman at a maul
Barchart · Feb 11 Thermo Fisher Scientific Stock Outlook: Is Wall Street Bullish or Bearish? Although Thermo Fisher Scientific has underperformed the broader market over the past 52 weeks, Wall Street analysts maintain a highly optimistic outlook about the stock’s prospects.
Barchart · Dec 30, 2025 What to Expect From Thermo Fisher Scientific's Next Quarterly Earnings Report Thermo Fisher Scientific will release its fourth-quarter earnings next month, and analysts anticipate a single-digit bottom-line growth.
The Guardian - UK · Dec 27, 2025 Tommy Freeman hat-trick topples Bath and sends Northampton to Prem summit An understrength Northampton ran in six tries at the Rec to leapfrog their rivals in the table and inflict Bath’s first home Prem defeat in more than a year
Benzinga · Dec 4, 2025 Thermo Fisher Teams Up With UK Firm To Scale Genetic Heart Disease Screening UK-based GENinCode PLC unveiled a wide-ranging commercial partnership with Thermo Fisher Scientific Inc (NYSE:TMO) to manufacture, sell, and distribute its CARDIO inCode-Score test.
Barchart · Nov 26, 2025 Thermo Fisher Scientific Stock: Is TMO Outperforming the Health Care Sector? Thermo Fisher Scientific has outperformed the broader healthcare sector over the past year, and analysts continue to hold a strongly bullish view on its growth prospects.
MarketBeat · Nov 19, 2025 Institutions Love These 3 Companies, Should You As Well? Retail investors seeking companies vetted by professionals might look to these three companies, all of which are heavily owned by institutional investors.
MarketBeat · Nov 18, 2025 These 3 Stocks Are Using Buybacks to Signal Market Confidence Buybacks are getting a boost at three $20B to $200B firms. Does Trade Desk's repurchase authorization signal confidence, or is it too early to tell?
Benzinga · Oct 29, 2025 Thermo Fisher To Acquire Clario Holdings For $8.875 Billion, Expands Digital Pharma Capabilities Thermo Fisher Scientific (NYSE:TMO) shares are trading higher on Wednesday after the company inked a deal to acquire Clario Holdings for $8.875 billion in cash, plus potential future earnout and other performance-based payments.
Benzinga · Oct 23, 2025 Thermo Fisher Scientific Analysts Increase Their Forecasts After Upbeat Q3 Earnings Thermo Fisher Scientific Inc (NYSE:TMO) reported better-than-expected earnings for the third quarter on Wednesday.
Benzinga · Oct 22, 2025 Thermo Fisher's Upbeat Earnings Suggest Worst Is Over For Scientific Tools Sector, Analyst Says Thermo Fisher Scientific Inc. (NYSE:TMO) on Wednesday reported third-quarter 2025 adjusted earnings of $5.79 per share, beating the street view of $5.49.